Showing 1 - 1 of 1
Objective: To determine the cost effectiveness of adjunctive therapy with entacapone versus standard treatment (levodopa) without entacapone for patients in the US with Parkinson's disease (PD) who experience `off-time' (re-emergence of the symptoms of PD) while receiving levodopa. Study Design:...
Persistent link: https://www.econbiz.de/10005590388